Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults

• Príomhchruthaitheoirí: Xavier Sáez-Llorens (Údar), Johnny Beltran-Rodriguez (Údar), Jose M. Novoa Pizarro (Údar), Ilhem Mensi (Údar), Pavitra Keshavan (Údar), Daniela Toneatto (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Taylor & Francis Group, 2018-05-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

This open-label, multicenter extension study (NCT02451514) assessed persistence of Neisseria meningitidis serogroups ABCWY antibodies 4 years after primary vaccination. Adolescents and young adults who previously received 2 doses of MenABCWY+OMV (Group III), 1 dose of MenACWY-CRM (Group VI), or newl...